|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2025―Jan―30 |
Global Research on the Treatment of Cancer Patients during the COVID-19 Pandemic: Visualization and Bibliometric Analysis |
Ting Chen, Yueling Wang, Ruixiang Xie, Liangliang Dong, Juming Chen, Lin Yang |
2 |
[GO] |
2024―Dez―04 |
Алгоритм ухвалення рішень для визначення моделі прогнозування оцінки впливу пандемії COVID-19 на онкоепідеміологічний процес в Україні |
|
3 |
[GO] |
2024―Dez―04 |
Прогнозування розвитку онкоепідеміологічного процесу в Україні та вивчення його особливостей в умовах глобальної пандемії COVID-19 |
|
4 |
[GO] |
2024―Jun―18 |
Exploring the Potential Link Between COVID-19, MiRNA Dysregulation, and Oral Cancer Risk in Tobacco Chewers |
Dhanraj Ganapathy, Saravanan Sekaran, Pasiyappazham Ramasamy |
5 |
[GO] |
2024―Jan―16 |
Decline in Cancer Diagnoses during the ‘Zero COVID’ Policy in Hong Kong: Indirect Spillover Impact of the COVID-19 Pandemic |
H.M. Youn, Y. Zhang, A. Liu, C.S. Ng, J. Liang, G.K.K. Lau, et al. (+5) S.F. Lee, J. Lok, C.L.K. Lam, E.Y.F. Wan, J. Quan |
6 |
[GO] |
2023―Jul―22 |
Impact of the COVID-19 Pandemic on Outcomes for Patients with Lung Cancer Receiving Curative-intent Radiotherapy in the UK |
I. Fornacon-Wood, K. Banfill, S. Ahmad, A. Britten, C. Carson, N. Dorey, et al. (+19) M. Hatton, C. Hiley, K. Thippu Jayaprakash, A. Jegannathen, A.C. Kidd, P. Koh, N. Panakis, C. Peedell, A. Peters, A. Pope, C. Powell, C. Stilwell, B. Thomas, E. Toy, K. Wicks, V. Wood, S. Yahya, G. Price, C. Faivre-Finn |
7 |
[GO] |
2023―Jun―06 |
Impact of COVID-19 Pandemic on Radiotherapy Interruptions and Patient Outcomes |
Chen-Xiong Hsu, Tien-Chi Li |
8 |
[GO] |
2023―Mai―23 |
Regarding ‘Impact of the COVID-19 Outbreak on Cancer Staging in Brazil’: Navigating the Impact of the Pandemic on Neuro-oncology Procedures |
Lucas Piason de Freitas Martins, Vanessa Emanuelle Cunha Santos, Isabela Mascarenhas de Andrade, Nícollas Nunes Rabelo |
9 |
[GO] |
2023―Mai―05 |
COVID-19 Vaccination Safety Profiles in Patients With Solid Tumour Cancers: comment |
A. Kleebayoon, V. Wiwanitkit |
10 |
[GO] |
2023―Mrz―22 |
Impact of the COVID-19 Outbreak on Cancer Staging in Brazil |
C.F.P.M. de Sousa, G. de Castro Junior, M.T.M. Starling, F.C.F. Restini, A.N. Rodrigues, H.S. de Castro Ribeiro, et al. (+4) G.V. Arruda, S.A. Hanna, F.Y. de Moraes, G.N. Marta |
11 |
[GO] |
2023―Mrz―15 |
COVID-19 Vaccination Safety Profiles in Patients with Solid Tumour Cancers: a Systematic Review |
S.L. Shear, K. Shams, J. Weisberg, N. Hamidi, S.C. Scott |
12 |
[GO] |
2023―Jan―17 |
Global Health System Resilience during Encounters with Stressors - Lessons Learnt from Cancer Services during the COVID-19 Pandemic |
K. Yeoh, Y. Wu, S. Chakraborty, G. Elhusseiny, S. Gondhowiardjo, N. Joseph, et al. (+8) A.W.M. Lee, H.H. Loong, S.C. Msadabwe-Chikuni, B.F. Tan, A.V. Ospina, T. Roques, H.M. Shum, E.K. Yeoh |
13 |
[GO] |
2023―Jan―12 |
Impact of COVID-19 on Management of MIBC: a Quantitative and Temporal Analysis |
S.H. Kombathula, M. Anjanappa, Y.P. Song, R. Conroy, J. Wylie, A. Choudhury |
14 |
[GO] |
2023―Jan―12 |
Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19 |
A. Gould, A. Muse, A. Thomson, J. McGrane |
15 |
[GO] |
2022―Nov―30 |
The Impact of COVID-19 on Radiotherapy Services in Scotland, UK: a Population-based Study |
L. Grocutt, A. Rutherford, D. Caldwell, C. Wilkinson, A.J. Chalmers, L. Dempsey, et al. (+2) C. Kelly, S.M. O’Cathail |
16 |
[GO] |
2022―Nov―04 |
Single institution outcomes of conventional (1.8-2 Gy/Fr) and hypofractionated (2.5-3 Gy/Fr) RT in OG/GOJ cancers during COVID-19 |
CL Lee, Maria Hawkins, Douglas Brand, Glen Blackman, Thomas Richards |
17 |
[GO] |
2022―Nov―04 |
Implementation of a drive-through/courier service for collecting oral anti-cancer medicines in response to the COVID-19 pandemic |
Tahir Patel, Lai Cheng Yew |
18 |
[GO] |
2022―Sep―15 |
The National Lung Cancer Audit: the Impact of COVID-19 |
J. Conibear, J. Nossiter, C. Foster, D. West, D. Cromwell, N. Navani |
19 |
[GO] |
2022―Sep―15 |
Managing high-grade gliomas during the first wave of the COVID-19 pandemic in London |
Jennifer van Griethuysen, Ciaran Hill, Medhi Khan, Zhangjie Su, Abhiney Jain, Naomi Fersht, et al. (+2) Michael Kosmin, David Choi |
20 |
[GO] |
2022―Sep―15 |
Peer review during COVID-19: Is it possible? |
Maeve Keys, William Croxford, Anna France, Cy Howells, Ed Smith, Shermaine Pan |
21 |
[GO] |
2022―Mai―31 |
Change in the Use of Fractionation in Radiotherapy Used for Early Breast Cancer at the Start of the COVID-19 Pandemic: a Population-based Cohort Study of Older Women in England and Wales |
M.R. Gannon, D. Dodwell, K. Miller, K. Horgan, K. Clements, J. Medina, et al. (+2) I. Kunkler, D.A. Cromwell |
22 |
[GO] |
2022―Mrz―16 |
Rapid Adaptation of Acute Oncology Services in One of the UK’s Largest NHS Foundation Trusts; Responding to COVID-19 and Beyond |
H. Boyce, H. Rickards, C. Wilson |
23 |
[GO] |
2022―Mrz―16 |
The COVID-19 Pandemic - A Cause for Late Presentation of Sarcoma Patients? |
W. Croxford, A. Kirwadi, A. Kumar, C. Coyle |
24 |
[GO] |
2022―Mrz―10 |
Preparing Breast Cancer Patients for Radiotherapy Treatment in the COVID-19 Era |
D. Hanna, E. Halliday, S. Needleman |
25 |
[GO] |
2022―Mrz―10 |
Impact of the COVID-19 Pandemic in Treating Breast Cancer (BC) Patients Receiving Systemic Anti-cancer Treatment (SACT): The Guy's Cancer Centre Experience |
C. Gousis, E. Tsotra, B. Russell, C. Moss, A. Mera, M. Van Hemelrijck, S. Dolly |
26 |
[GO] |
2022―Feb―07 |
The Impact of the COVID-19 Pandemic on Uro-oncology Admissions at a UK Tertiary Cancer Centre: Clinical Severity and Outcomes |
M. Kayani, P. Sawnhey, P. Agarwal, U. McGovern |
27 |
[GO] |
2021―Nov―19 |
The Importance of Tackling the Social Determinants of Health to Address the Unmet Need within Cancer Services. Reflections from Build Back Fairer: the COVID-19 Marmot Review |
A. Spencer, B. Watermeyer, A. Rogers |
28 |
[GO] |
2021―Okt―28 |
Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK |
K. Banfill, W. Croxford, I. Fornacon-Wood, K. Wicks, S. Ahmad, A. Britten, et al. (+19) C. Carson, N. Dorey, M. Hatton, C. Hiley, K. Thippu Jayaprakash, A. Jegannathen, P. Koh, N. Panakis, C. Peedell, A. Pope, C. Powell, C. Stilwell, B. Thomas, E. Toy, V. Wood, S. Yahya, S.Y. Zhou, G. Price, C. Faivre-Finn |
29 |
[GO] |
2021―Okt―11 |
Клінічна ефективність інгібіторів тирозинкінази у пацієнтів з НДРЛ та рідкісними EGFR-мутаціями: результати клінічних досліджень та власний досвід лікування пацієнта з НДРЛ на фоні COVID-19 |
|
30 |
[GO] |
2021―Jul―09 |
COVID-19 Vaccination in Oncology Patients Receiving Chemotherapy |
R. Mungmungpuntipantip, V. Wiwanitkit |
31 |
[GO] |
2021―Apr―24 |
SARS-CoV-2 infection and antibody seroprevalence among UK healthcare professionals working with cancer patients during the first wave of the COVID-19 pandemic |
D.M. Favara, K. McAdam, A. Cooke, A. Bordessa-Kelly, I. Budriunaite, S. Bossingham, et al. (+4) S. Houghton, R. Doffinger, N. Ainsworth, P.G. Corrie |
32 |
[GO] |
2021―Mrz―29 |
Corrigendum to “Considerations for the Treatment of Oesophageal Cancer with Radiotherapy During the COVID-19 Pandemic” [Clin Oncol 32 (2020) 354-357] |
C.M. Jones, M. Hawkins, S. Mukherjee, G. Radhakrishna, T. Crosby |
33 |
[GO] |
2021―Mrz―02 |
COVID-19 Vaccine Prioritisation for Medical Students: the Forgotten Cohort? |
J.S. Lim, T.P.T. Au Yong, C.S. Boon, I.S. Boon |
34 |
[GO] |
2021―Feb―25 |
Mental Health Impact of COVID-19 in Radiation Oncology Health Care Workers of Asian Countries |
A. Kumar, T. Wadasadawala, S.G. Laskar, S. Gondhowiardjo, J.P. Agarwal |
35 |
[GO] |
2021―Jan―19 |
Keep calm and carry on: safety, feasibility and early outcomes of head and neck cancer treatment during the COVID-19 pandemic |
S. Walker, C. Paterson |
36 |
[GO] |
2020―Dez―24 |
Adjuvant Breast Radiotherapy at an Academic Centre during the COVID-19 Pandemic: Reassuringly Safe |
N. Hanumanthappa, C. Goldsmith, E. Sawyer, A. Tutt, F. Castell, G. Azad, et al. (+6) V. Mullassery, S. Ahmad, J. Timbres, A. Mera, A. Swampillai, D. Smith |
37 |
[GO] |
2020―Dez―24 |
Optimal Timing for COVID-19 Vaccination in Oncology Patients Receiving Chemotherapy? |
A. Sudan, R. Iype, C. Kelly, M.S. Iqbal |
38 |
[GO] |
2020―Dez―02 |
Accelerated Adaptation of Ultrahypofractionated Radiation Therapy for Breast Cancer at the Time of the COVID-19 Pandemic |
M. Machiels, R. Weytjens, W. Bauwens, W. Vingerhoed, C. Billiet, P. Huget, et al. (+5) D. Verellen, P. Dirix, P. Meijnders, P. Poortmans, O. Kaidar-Person |
39 |
[GO] |
2020―Nov―19 |
Clinical Characteristics and Outcomes in Patients with COVID-19 and Cancer: a Systematic Review and Meta-analysis |
P. Zarifkar, A. Kamath, C. Robinson, N. Morgulchik, S.F.H. Shah, T.K.M. Cheng, et al. (+12) C. Dominic, A.O. Fehintola, G. Bhalla, T. Ahillan, L. Mourgue d'Algue, J. Lee, A. Pareek, M. Carey, D.J. Hughes, M. Miller, V. Woodcock, M. Shrotri |
40 |
[GO] |
2020―Nov―17 |
Estimating the Risk of Death from COVID-19 in Adult Cancer Patients |
M. Williams, E. Mi, K. Le Calvez, J. Chen, L. Pakzad-Shahabi, S. Dadhania, et al. (+3) J. Wang, A. Ho, S. Rabinowicz |
41 |
[GO] |
2020―Nov―12 |
The COVID-19 Pandemic as a Catalyst for a National Cancer Imaging Repository: Answering the Topol Review |
I.S. Boon, M.H. Yap, T.P.T. Au Yong, C.S. Boon |
42 |
[GO] |
2020―Nov―09 |
To Curb the Impact of COVID-19 on the Provision of Cancer Care, What Role will Rapid Antigen Testing Play? |
O.R. Barnes |
43 |
[GO] |
2020―Nov―04 |
Prostate Ultrahypofractionation - Rising to Challenges Presents Opportunities in the COVID-19 Era |
W. Griffiths, J.A. Frew, R. Chandler, X.Y. Jiang, I.D. Pedley, R.A. Pearson |
44 |
[GO] |
2020―Okt―28 |
Three Proposals to Optimise the Eastern Cooperative Oncology Group and Karnofsky Scales in the Molecular and COVID-19 Era |
A. Ponzetti, R. Laface, E. Milanesi, L. Ciuffreda |
45 |
[GO] |
2020―Okt―20 |
Cancer During the Coronavirus Pandemic - As if One Problem Was Not Enough! |
N. Patni, A. Hota, A. Patni, P. Misra |
46 |
[GO] |
2020―Okt―13 |
How Useful is COVID-19 Antibody Testing - a Current Assessment for Oncologists |
P.A.C. Maple, K. Sikora |
47 |
[GO] |
2020―Sep―06 |
Flash Survey on the Effect of COVID-19 on Radiotherapy Services in the UK - the Benefit of Social Media for Rapid Information Gathering for the Radiotherapy Community and Government |
S. Ashcroft, K. Meeking, P. Price |
48 |
[GO] |
2020―Sep―02 |
COVID RT - Assessing the Impact of COVID-19 on Radiotherapy in the UK. A National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group Initiative in Partnership with the Royal College of Radiologists, the Society of Radiographers and the Institute of Physics and Engineering in Medicine |
P.J. Lewis, E.J.A. Morris, C.S.K. Chan, K. Darley, D. Sebag-Montefiore, M. Evans |
49 |
[GO] |
2020―Aug―20 |
Patient-reported Experience Measure for Neuro-oncology Telephone Clinics during the COVID-19 Pandemic |
P. Ghimire, J.P. Lavrador, L. Onyiriuka, C. Robinson, J. La, L. Mullens, et al. (+9) V. Hurwitz, K. Cikurel, O. Al-Salihi, A. Swampillai, L. Brazil, R. Bhangoo, F. Vergani, R. Gullan, K. Ashkan |
50 |
[GO] |
2020―Aug―14 |
Personal View: Low-dose Lung Radiotherapy Should be Evaluated as a Treatment for Severe COVID-19 Lung Disease |
D. Hadjiyiannakis, D. Dimitroyannis, L. Eastlake, C. Peedell, L. Tripathi, R. Simcock, et al. (+3) A. Vyas, E. Deutsch, A.J. Chalmers |
51 |
[GO] |
2020―Aug―04 |
Clinical Outcome of Breast Cancer Patients on Chemotherapy during the COVID-19 Pandemic in South Korea |
Soo Jung Lee, Juhyung Kim, Yee Soo Chae |
52 |
[GO] |
2020―Jul―30 |
The shift towards digital appointments: the response to COVID-19 affecting Uro-Oncology |
E. Scott, M. Kubiak, S. Needleman, G. Marks, K. Smith, M. Prentice, et al. (+6) E. Scott, M. Kubiak, S. Needleman, G. Marks, K. Smith, M. Prentice |
53 |
[GO] |
2020―Jul―29 |
Cancer Australia's Response to the COVID-19 Pandemic |
V. Milch, D. Hector, S. Turnbull, R. Sathiaraj, P. Jackson, C. Anderiesz, D. Keefe |
54 |
[GO] |
2020―Jul―25 |
COVID-19 Serology in Oncology Staff Study: Understanding SARS-CoV-2 in the Oncology Workforce |
D.M. Favara, A. Cooke, R. Doffinger, K. McAdam, P. Corrie, N.L. Ainsworth |
55 |
[GO] |
2020―Jul―08 |
Evidence is Lacking for the NHS England Interim Guidance for Managing Metastatic Non-small Cell Lung Cancer in the COVID-19 Pandemic |
M. Choudhury, S. Nageshwaran, D. Muthukumar |
56 |
[GO] |
2020―Jul―01 |
Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic: Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-up |
S.H. Nahm, A. Rembielak, H. Peach, P.C. Lorigan |
57 |
[GO] |
2020―Jun―10 |
Personal View: Low-dose Lung Radiotherapy for COVID-19 Pneumonia - The Atypical Science and the Unknown Collateral Consequence |
H. Tharmalingam, P. Díez, Y. Tsang, A. Hawksley, J. Conibear, N. Thiruthaneeswaran |
58 |
[GO] |
2020―Jun―09 |
COVID-19 Pandemic and Nationwide Lockdown - Implications of the Double Trouble on Radiotherapy Practice in India |
N. Mummudi, S. Ghosh-Laskar, A. Tibdewal, J.P. Agarwal |
59 |
[GO] |
2020―Jun―09 |
Adjuvant Systemic Anti-cancer Therapy in Early Breast Cancer During the COVID-19 Pandemic: Differences between Clinicians and Patients in Perception of Treatment Risks and Benefits |
E.R. Gatfield, M.B. Mukesh, S.W. Loo |
60 |
[GO] |
2020―Jun―05 |
Coronavirus Disease 2019: the Pivotal Role of UK Clinical Oncology and the UK Coronavirus Cancer Monitoring Project |
J. Best, T. Starkey, A. Chaterjee, D. Fackrell, L. Pettit, N. Srihari, et al. (+11) H. Tween, A. Olsson-Brown, V. Cheng, D.J. Hughes, A.J.X. Lee, K. Purshouse, R. Arnold, C. Palles, S. Sivakumar, J.-B. Cazier, L.Y.W. Lee |
61 |
[GO] |
2020―Mai―27 |
The Impact of the Acute Phase of COVID-19 on Radiotherapy Demand in South East Wales |
E. Higgins, S. Walters, E. Powell, J. Staffurth |
62 |
[GO] |
2020―Mai―23 |
Effectiveness of Clinical Examination in Cancer Surveillance: New Paradigm to Cancer Survivorship Beyond the COVID-19 Pandemic |
I.S. Boon, T.P.T. Au Yong, C.S. Boon |
63 |
[GO] |
2020―Mai―20 |
COVID-19 Pandemic as an Opportunity for the Radiotherapy Department |
M. Orazem, I. Ratosa |
64 |
[GO] |
2020―Mai―19 |
The Response of the UK Clinical Oncology Community to the COVID-19 Pandemic |
P.J. Lewis, T.W. Roques |
65 |
[GO] |
2020―Mai―13 |
Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic |
C. Faivre-Finn, J.D. Fenwick, K.N. Franks, S. Harrow, M.Q.F. Hatton, C. Hiley, et al. (+8) J.J. McAleese, F. McDonald, J. O'Hare, C. Peedell, C. Powell, T. Pope, R. Rulach, E. Toy |
66 |
[GO] |
2020―Mai―07 |
Radiotherapy and Systemic Treatment for Non-melanoma Skin Cancer in the COVID-19 Pandemic |
A. Rembielak, A.J. Sykes, K. Fife, A. Challapalli, J.P. Nobes |
67 |
[GO] |
2020―Mai―01 |
Liver Stereotactic Ablative Radiotherapy: an Effective and Feasible Alternative to Surgery during the COVID-19 Pandemic |
K. Aitken, J. Good, M. Hawkins, D. Grose, S. Mukherjee, M. Harrison, G. Radhakrishna |
68 |
[GO] |
2020―Mai―01 |
SARS-CoV-2 Transmission in Patients With Cancer still being depicted |
Juan Tan, Chao Yang |
69 |
[GO] |
2020―Apr―30 |
Lymphocytopenia and Radiotherapy Treatment Volumes in the Time of COVID-19 |
N. Joseph, A. Choudhury |
70 |
[GO] |
2020―Apr―27 |
Challenges and Consequences of COVID-19 in the Management of Anorectal Cancer: Coming Together Through Social Distancing |
S.M. O'Cathail, D.C. Gilbert, D. Sebag-Montefiore, R. Muirhead |
71 |
[GO] |
2020―Apr―25 |
Effect of the COVID-19 Pandemic on Cancer Clinician Decision Making: Known Knowns and Known Unknowns |
I.S. Boon, T.P.T. Au Yong, C.S. Boon |
72 |
[GO] |
2020―Apr―24 |
Clinical Guidance for the Management of Patients with Urothelial Cancers During the COVID-19 Pandemic - Rapid Review |
Karan Patel, Ananya Choudhury, Peter Hoskin, Mohini Varughese, Nicholas James, Robert Huddart, Alison Birtle |
73 |
[GO] |
2020―Apr―23 |
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy |
B.A. Jereczek-Fossa, M.F. Palazzi, C.P. Soatti, L.F. Cazzaniga, G.B. Ivaldi, M. Pepa, et al. (+31) M. Amadori, P. Antognoni, S. Arcangeli, A. Buffoli, G. Beltramo, S. Berlinghieri, M. Bignardi, S. Bracelli, L. Bruschieri, S. Castiglioni, G. Catalano, N. Di Muzio, C. Fallai, L. Fariselli, A.R. Filippi, A. Gramaglia, C. Italia, F. Lombardi, S.M. Magrini, S. Nava, E. Orlandi, N. Pasinetti, E.L. Sbicego, L. Scandolaro, M. Scorsetti, F. Stiglich, S. Tonoli, R. Tordini, R. Valdagni, V. Vavassori, G. Marvaso |
74 |
[GO] |
2020―Apr―23 |
Managing the COVID-19 Pandemic as a National Radiation Oncology Centre in Singapore |
B.F. Tan, J.K.L. Tuan, S.P. Yap, S.Z. Ho, M.L.C. Wang |
75 |
[GO] |
2020―Apr―09 |
Considerations for the Treatment of Oesophageal Cancer With Radiotherapy During the COVID-19 Pandemic |
C.M. Jones, M. Hawkins, S. Mukherjee, G. Radhakrishna, T. Crosby |
76 |
[GO] |
2020―Apr―06 |
Full Spectrum of Cancer Patients in SARS-CoV-2 Infection Still Being Described |
X. Liang, C. Yang |
77 |
[GO] |
2020―Mrz―31 |
International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic |
C.E. Coles, C. Aristei, J. Bliss, L. Boersma, A.M. Brunt, S. Chatterjee, et al. (+11) G. Hanna, R. Jagsi, O. Kaidar Person, A. Kirby, I. Mjaaland, I. Meattini, A.M. Luis, G.N. Marta, B. Offersen, P. Poortmans, S. Rivera |
|